Eli Lilly said Wednesday it will build three manufacturing plants in the United States to make the key raw ingredients in its medicines, a push to bring home a critical part of the pharmaceutical ...

Eli Lilly plans to spend at least $27bn to build four new manufacturing plants in the United States, the drugmaker has said as it grapples with the threat of drug import duties from the Trump ...

Drugmaker Eli Lilly plans to invest up to $27 billion to ... Two separate budget resolutions have advanced in the House and Senate as part of kicking off the legislative process that lawmakers ...

The new manufacturing sites are expected to create create 3,000 pharmaceutical jobs and nearly 10,000 construction positions during the buildout.

It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares ...

Drug companies are keen to develop close relations with the current White House, which has promised ... For more, read: Eli Lilly cuts price of weight-loss drug Zepbound as competition heats ...

The new plants will be built over the next five years, and are expected to create more than 3,000 jobs for skilled workers.